<p>，/PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否存在潛在的聯邦證券法違規和/或對股東的信託責任違反，涉及：</p>
<p><strong>iTeos Therapeutics, Inc. (NASDAQ: ITOS)</strong> 向 Concentra Biosciences, LLC 的出售。根據擬議交易的條款，Concentra 將以每股 10.047 美元的現金收購 iTeos，並附帶一項不可轉讓的或有價值權利，代表有權獲得：(i) iTeos 超過 4.75 億美元的結算淨現金的 100%；以及 (ii) 在結算後六個月內，iTeos 的某些產品候選者處置所獲得的任何淨收益的 80%。<strong>如果您是 iTeos 的股東，</strong> <strong>請點擊這裏瞭解您的權利和選擇</strong> <strong>。</strong></p>
<p><strong>WK Kellogg Co (NYSE: KLG)</strong> 向費列羅集團出售，每股現金 23.00 美元。<strong>如果您是 Kellogg 的股東，請點擊這裏瞭解您的法律權利和選擇</strong>。</p>
<p>Halper Sadeh LLC 可能會尋求為股東爭取更高的對價、額外的披露和有關擬議交易的信息，或代表股東尋求其他救濟和利益。<strong>我們將以風險代理的方式處理此行動，您無需承擔我們的法律費用或開支。</strong></p>
<p>鼓勵股東與本事務所 <strong>免費</strong> 聯繫，以討論他們的法律權利和選擇。請致電 Daniel Sadeh 或 Zachary Halper，電話 (212) 763-0060，或發送電子郵件至 [email protected] 或 [email protected]。</p>
<p>Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。</p>
<p>律師廣告。以往的結果並不保證類似的結果。</p>
<p>聯繫信息：</p>
<p>Halper Sadeh LLC</p>
<p>Daniel Sadeh，律師。</p>
<p>Zachary Halper，律師。</p>
<p>(212) 763-0060</p>
<p>[email protected]</p>
<p>[email protected]</p>
<p>https://www.halpersadeh.com</p>
<p>來源 Halper Sadeh LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwODIwJk5ld3NJdGVtSWQ9Tlk1NTQ2MCZUcmFuc21pc3Npb25fSWQ9MjAyNTA4MjAxMTA1UFJfTkVXU19VU1BSX19fX19OWTU1NDYw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwODIwJk5ld3NJdGVtSWQ9Tlk1NTQ2MCZUcmFuc21pc3Npb25fSWQ9MjAyNTA4MjAxMTA1UFJfTkVXU19VU1BSX19fX19OWTU1NDYw"/></p>

ITOS

<p>Halper Sadeh LLC 正在調查 iTeos Therapeutics, Inc.（納斯達克代碼：ITOS）和 WK Kellogg Co（紐約證券交易所代碼：KLG）是否存在潛在的聯邦證券法違規行為和對股東的信託責任違反。調查涉及 iTeos 以每股 10.047 美元出售給 Concentra Biosciences 以及 Kellogg 以每股 23.00 美元出售給費列羅集團。該公司可能會尋求為股東提供更高的補償，並鼓勵他們討論自己的法律權利和選擇</p>

<p>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否存在潛在的聯邦證券法違規和/或對股東的信託責任違反，涉及：</p>
</div><p><strong>iTeos Therapeutics, Inc. (NASDAQ: ITOS)'s</strong> sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Concentra will acquire iTeos for $10.047 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of iTeos in excess of $475 million; and (ii) 80% of any net proceeds received from any disposition of certain of iTeos' product candidates that occurs within six months following the closing. <strong>If you are an iTeos shareholder,</strong> <strong>click here to learn more about your rights and options</strong> <strong>.</strong></p>
<div class="lb-trans"><p><strong>iTeos Therapeutics, Inc. (NASDAQ: ITOS)</strong> 向 Concentra Biosciences, LLC 的出售。根據擬議交易的條款，Concentra 將以每股 10.047 美元的現金收購 iTeos，並附帶一項不可轉讓的或有價值權利，代表有權獲得：(i) iTeos 超過 4.75 億美元的結算淨現金的 100%；以及 (ii) 在結算後六個月內，iTeos 的某些產品候選者處置所獲得的任何淨收益的 80%。<strong>如果您是 iTeos 的股東，</strong> <strong>請點擊這裏瞭解您的權利和選擇</strong> <strong>。</strong></p>
</div><p><strong>WK Kellogg Co (NYSE: KLG)'s</strong> sale to The Ferrero Group for $23.00 per share in cash. <strong>If you are a Kellogg shareholder, click here to learn more about your legal rights and options</strong>.</p>
<div class="lb-trans"><p><strong>WK Kellogg Co (NYSE: KLG)</strong> 向費列羅集團出售，每股現金 23.00 美元。<strong>如果您是 Kellogg 的股東，請點擊這裏瞭解您的法律權利和選擇</strong>。</p>
</div><p>Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. <strong>We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.</strong></p>
<div class="lb-trans"><p>Halper Sadeh LLC 可能會尋求為股東爭取更高的對價、額外的披露和有關擬議交易的信息，或代表股東尋求其他救濟和利益。<strong>我們將以風險代理的方式處理此行動，您無需承擔我們的法律費用或開支。</strong></p>
</div><p>Shareholders are encouraged to contact the firm <strong>free of charge</strong> to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].</p>
<div class="lb-trans"><p>鼓勵股東與本事務所 <strong>免費</strong> 聯繫，以討論他們的法律權利和選擇。請致電 Daniel Sadeh 或 Zachary Halper，電話 (212) 763-0060，或發送電子郵件至 [email protected] 或 [email protected]。</p>
</div><p>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.</p>
<div class="lb-trans"><p>Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律師廣告。以往的結果並不保證類似的結果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>聯繫信息：</p>
</div><p>Halper Sadeh LLC</p>
<div class="lb-trans"><p>Halper Sadeh LLC</p>
</div><p>Daniel Sadeh, Esq.</p>
<div class="lb-trans"><p>Daniel Sadeh，律師。</p>
</div><p>Zachary Halper, Esq.</p>
<div class="lb-trans"><p>Zachary Halper，律師。</p>
</div><p>(212) 763-0060</p>
<div class="lb-trans"><p>(212) 763-0060</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>https://www.halpersadeh.com</p>
<div class="lb-trans"><p>https://www.halpersadeh.com</p>
</div><p>SOURCE Halper Sadeh LLP</p>
<div class="lb-trans"><p>來源 Halper Sadeh LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwODIwJk5ld3NJdGVtSWQ9Tlk1NTQ2MCZUcmFuc21pc3Npb25fSWQ9MjAyNTA4MjAxMTA1UFJfTkVXU19VU1BSX19fX19OWTU1NDYw" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY55460&amp;Transmission_Id=202508201105PR_NEWS_USPR_____NY55460&amp;DateId=20250820"/></p>

股東調查：Halper Sadeh LLC 代表股東對 iTeos Therapeutics 和 WK Kellogg 進行調查